Archives of Clinical Infectious Diseases
Infectious Diseases and Tropical Medicine Research Center, SBUMS
OpenAlex
Works that cite this article, indexed by OpenAlex.
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Computational and Structural Biotechnology Journal 18 (2020)
Bo Ram Beck; Bonggun Shin; Yoonjung Choi; Sung‐Soo Park; Keunsoo Kang
Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates
F1000Research 9 (2020)
Yu Wai Chen; Chin-Pang Bennu Yiu; Kwok‐Yin Wong
Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates
F1000Research 9 (2020)
Yu Wai Chen; Chin-Pang Bennu Yiu; Kwok‐Yin Wong
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
Current Medicinal Chemistry 27(27) (2020)
Michele Costanzo; Maria Anna Rachele De Giglio; Giovanni Nicola Roviello
Current pharmacological treatments for COVID‐19: What's next?
British Journal of Pharmacology 177(21) (2020)
Cristina Scavone; Simona Brusco; Michele Bertini; Liberata Sportiello; Concetta Rafaniello; Alice Zoccoli; Liberato Berrino; Giorgio Racagni; Francesco Rossi; Annalisa Capuano
Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study
Informatics in Medicine Unlocked 19 (2020)
Karlapudi Abraham Peele; Chandrasai Potla Durthi; T. Srihansa; S. Krupanidhi; Vijaya Sai Ayyagari; D. John Babu; M. Indira; Aluru Ranganadha Reddy; Thirupati Chinna Venkateswarulu
In silico investigation of phytoconstituents from Indian medicinal herb ‘Tinospora cordifolia(giloy)’ against SARS-CoV-2 (COVID-19) by molecular dynamics approach
Journal of Biomolecular Structure and Dynamics 39(17) (2020)
Papia Chowdhury
Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design
International Journal of Molecular Sciences 21(9) (2020)
Maria Bzówka; Karolina Mitusińska; Agata Raczyńska; Aleksandra Samol; Jack A. Tuszyński; Artur Góra
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
Journal of the International AIDS Society 23(4) (2020)
Nathan Paul Ford; Marco Vitória; Ajay Rangaraj; Susan L. Norris; Alexandra Calmy; Meg C. Doherty
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
Frontiers in Pharmacology 11 (2020)
Surjeet Verma; Danielle Twilley; Tenille Esmear; Carel B. Oosthuizen; Anna-Mari Reid; Marizé Cuyler; Namrita Lall
Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India
The Indian Journal of Medical Research 151(2-3) (2020)
Tarun Bhatnagar; Manoj Vasanth Murhekar; Manish Soneja; Nivedita Gupta; Sidhartha Giri; Naveet Wig; Raman Gangakhedkar
Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock
VirusDisease 31(2) (2020)
Dipti Mothay; K. V. Ramesh
Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses
Molecules 25(8) (2020)
Nakarin Suwannarach; Jaturong Kumla; Kanaporn Sujarit; Thanawat Pattananandecha; Chalermpong Saenjum; Saisamorn Lumyong
Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus
International Journal of Biological Macromolecules 183 (2021)
Yuxi Guo; Xuefeng Chen; Pin Gong
Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
Indian Journal of Pharmacology 52(1) (2020)
Bikash Medhi; Phulen Sarma; Manisha Prajapat; Pramod Avti; Hardeep Kaur; Subodh Kumar
Emerging prophylaxis strategies against COVID-19
Monaldi Archives for Chest Disease 90(1) (2020)
Sumita Pravesh Agrawal; Akhil Dhanesh Goel; Nitesh Gupta
Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report
American Journal of Transplantation 20(7) (2020)
Ling Gui Ning; Lei Liu; Wenyuan Li; Hongtao Liu; Jizhou Wang; Ziqin Yao; Shengyu Zhang; Desheng Zhao; Björn Nashan; Aizong Shen; Lianxin Liu; Lei Li
Therapeutic opportunities of edible antiviral plants for COVID-19
Molecular and Cellular Biochemistry 476(6) (2021)
Bhoomika M. Patel; Supriya Sharma; Nisha Nair; Jaseela Majeed; Ramesh Kishorilal Goyal; Mahaveer Dhobi
Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19
Journal of Molecular Structure 1231 (2021)
Rageh K. Hussein; Hatim Mohamed El-Khair
Potential repurposed SARS-CoV-2 (COVID-19) infection drugs
RSC Advances 10(45) (2020)
Gamal El‐Din A. Abuo‐Rahma; Mamdouh F. A. Mohamed; Tarek Salah Ibrahim; Mai E. Shoman; Ebtihal Samir; Rehab Mahmoud Abd El-Baky
SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
Journal of Clinical Medicine 9(7) (2020)
Cristina Adriana Dehelean; Voichița Elena Lăzureanu; Dorina Elena Coricovac; Marius Mioc; Roxana Oancea; Iasmina Marcovici; Iulia Pînzaru; Codruţa Şoica; Aristidis Michael Tsatsakis; Octavian Marius Cretu
Vaccines and Therapies in Development for SARS-CoV-2 Infections
Journal of Clinical Medicine 9(6) (2020)
David Bin-Chia Wu; Raghuram Koganti; Upendra Pradeep Lambe; Tejabhiram Yadavalli; Shyam Sundar Nandi; Deepak Shukla
Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis
Pharmaceuticals 14(4) (2021)
Magdi E. A. Zaki; Sami A. Al‐Hussain; Vijay Hariram Masand; Siddhartha Akasapu; Sumit O. Bajaj; Nahed N. E. El-Sayed; Arabinda Ghosh; Israa Lewaa
SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
Journal of Gynecology Obstetrics and Human Reproduction 49(10) (2020)
Guilherme Antonio de Souza Silva; Suéllen Pedrosa da Silva; Marcos Aurélio Santos da Costa; Abdênego Rodrigues da Silva; Robson Raion de Vasconcelos Alves; Fernanda das Chagas Ângelo Mendes Tenório; Alanne Rayssa da Silva Melo; Antônio Carlos de Freitas; Cristiane Moutinho Lagos de Melo
Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews 13(2) (2021)
Supriya Roy; Suneela Sunil Dhaneshwar; Bhavya Bhasin
Insights into the inhibitory potential of selective phytochemicals against Mpro of 2019-nCoV: a computer-aided study
Structural Chemistry 31(5) (2020)
Nouman Rasool; Ammara Akhtar; Waqar Hussain
Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (Mpro) of SARS-CoV-2
Journal of Molecular Modeling 27(3) (2021)
Arabinda Ghosh; Monoswi Chakraborty; Anshuman Chandra; Mohamad Parvez Alam
Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study
Journal of Biomolecular Structure and Dynamics 40(12) (2021)
Vanderlan Nogueira Holanda; Elton Marlon de Araújo Lima; Welson Vicente da Silva; Rafael Trindade Maia; Rafael de Lima. MEDEIROS; Arabinda Ghosh; Vera Lúcia de Menezes Lima; Regina Célia Bressan Queiroz de Figueiredo
An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia
PLoS ONE 16(6) (2021)
Purwati Purwati; Andang Miatmoko; Nasronudin Nasronudin; Eryk Hendrianto; Deya Karsari; Aristika Dinaryanti; Nora Ertanti; Igo Syaiful Ihsan; Disca Sandyakala Purnama; Tri Pudy Asmarawati; Erika Marfiani; Yulistiani Yulistiani; Alfian Nur Rosyid; Prastuti Asta Wulaningrum; Herley Windo Setiawan; Imam Siswanto; Ni Nyoman Tri Puspaningsih
Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2
Molecular Biology and Evolution 38(2) (2020)
Erica Teixeira Prates; Michael R. Garvin; Mirko Pavicic; Piet C. Jones; Manesh B. Shah; Omar Demerdash; B Kirtley Amos; Armin Geiger; Daniel Jacobson
COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach
Drug Design Development and Therapy Volume 15 (2021)
Soha R. Abd El Hadi; Esmat E Zien El-Deen; Mostafa M. Bahaa; Abdelfattah A. Sadakah; Heba Yassin
Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction
Virology 604 (2025)
Ankita Saha; Shweta Choudhary; Priyanshu Walia; Pravindra Kumar; Shailly Tomar
In Silico Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of Nigella Sativa
Current Drug Discovery Technologies 18(4) (2020)
Youness Kadil; Mohammed Mouhcine; Houda Filali
Safety perspectives on presently considered drugs for the treatment of COVID‐19
British Journal of Pharmacology 177(19) (2020)
Sophie L. Penman; Robyn T. Kiy; Rebecca L. Jensen; Christopher Beoku Betts; Ana Alfirevic; David J. Back; Saye Khoo; Andrew Owen; Munir Pirmohamed; B. Kevin Park; Xiaoli Meng; Christopher E. Goldring; Amy E. Chadwick
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases
Infectious Disorders - Drug Targets 21(4) (2020)
Trinath Chowdhury; Gourisankar Roymahapatra; Santi M. Mandal
Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective
Journal of Pharmaceutical Sciences 110(3) (2020)
Simone Perazzolo; Linxi Zhu; Weixian Lin; Alexander Nguyen; Rodney J. Y. Ho
In silico studies of Potency and safety assessment of selected trial drugs for the treatment of COVID-19
In Silico Pharmacology 9(1) (2021)
Peter Ifeoluwa Adegbola; Olumide Samuel Fadahunsi; Aanuoluwa Eunice Adegbola; Banjo Semire
A multiple peptides vaccine against COVID-19 designed from the nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the immunoinformatics approach
Informatics in Medicine Unlocked 21 (2020)
Sahar Obi Abd Albagi; Mosab Yahya Al-Nour; Mustafa Elhag; Asaad Tageldein Idris Abdelhalim; Esraa Musa Haroun; Mohammed Elmujtba Adam Essa; Mustafa Abubaker; Hemchandra Deka; Arabinda Ghosh; Mohammed A. Hassan
COVID-19: только научные факты
Dalʹnevostočnyj medicinskij žurnal(1) (2020)
RETRACTED ARTICLE: A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort
European Journal of Clinical Microbiology & Infectious Diseases 40(2) (2020)
Yasemin Çağ; Sacit İçten; Burcu Isık Goren; Naciye Betül Baysal; Begüm Bektaş; Ece Selvi; Pınar Ergen; Özlem Aydın; Ayşe Canan Üçışık; Fatma Yılmaz Karadağ; Hülya Çaşkurlu; Tülin Akarsu Ayazoğlu; Hasan Koçoğlu; Sinan Uzman; Muge Nural-Pamukcu; Ferhat Arslan; Gürhan Baş; Mahmut Tayyar Kalcioglu; Haluk Vahaboğlu
Screening of potential anti-HIV compounds from Achyranthes aspera extracts for SARS-CoV-2: An insight from molecular docking study
Journal of Physics Conference Series 1797(1) (2021)
Tanmoy Dutta; Sajal Ghorai; Abdul Ashik Khan; Nabajyoti Baildya; Narendra Nath Ghosh
CAUSES OF DEATH AMONG MUSCOVITES BEFORE AND DURING THE COVID-19 PANDEMIC
Social Aspects of Population Health 66(4) (2020)
Tamara P. Sabgayda; Alla Ivanova; Sergey G. Rudnev; Victoria G. Semyonova
COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling
AIDS Care 34(7) (2021)
S. Q. Rocha; Vivian Iida Avelino‐Silva; Mariza Vono Tancredi; L. Jamal; Paulo Roberto Abrão Ferreira; Ângela Tayra; Patrícia Marques Ferreira; Telma Regina Marques Pinto Carvalhanas; Carmen Silvia Bruniera Domingues; Rita Adriana Gomes de Souza; Maria Clara Gianna; Artur Olhovetchi Kalichman; O. H. M. Leite; Tâmara Newman Lobato Souza; D. A. Gomes e Costa; Juvêncio José Duailibe Furtado; Angelo Costa; for the HIV-COVID/SP Study Group
Biophysics of SARS-CoV-2 spike protein’s receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights
Biophysical Reviews 17(2) (2025)
Fernando Luís Barroso da Silva; Karen Paco; Aatto Laaksonen; Animesh Ray
COVID-19: a wreak havoc across the globe
Archives of Physiology and Biochemistry 129(1) (2020)
Heena Rehman; Md Iftekhar Ahmad
Computational modeling of the pharmacological actions of some antiviral agents against SARS-CoV-2
Elsevier eBooks (2021)
Abayomi Emmanuel Adegboyega; Titilayo Omolara Johnson; Simeon Omale
Effects of the Temperature and the pH on the Main Protease of SARS-CoV-2: A Molecular Dynamics Simulation Study
Biointerface Research in Applied Chemistry 12(6) (2021)
Therapeutic approaches to coronavirus infection according to “One Health” concept
Research in Veterinary Science 136 (2021)
Giacomo Rossi; Livio Galosi; Alessandra Gavazza; Matteo Cerquetella; Sara Mangiaterra
The Balance between Two Branches of RAS Can Protect from Severe COVID-19 Course
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology 15(1) (2021)
Н. В. Бобкова
Targeting COVID-19 pandemic: in silico evaluation of 2-hydroxy-1, 2-diphenylethanone N(4)-methyl-N(4)-phenylthiosemicarbazone as a potential inhibitor of SARS-CoV-2
Structural Chemistry 34(5) (2022)
Rajan Jeevana; Abu Pilakkaveettil Kavitha; T. G. Abi; Pookkottu K. Sajith; Jibin K. Varughese; Kuttamath Kunniyur Aravindakshan
Integrating LC–MS/MS and In Silico Methods to Uncover Bioactive Compounds with Lipase Inhibitory Potential in the Antarctic Moss Warnstorfia fontinaliopsis
Applied Biochemistry and Biotechnology 197(4) (2025)
Hirotake Yamaguchi; Ryoichi Yamada; Kristina Lama; Ui Joung Youn; Jun Hyuck Lee; Tae‐Jin Oh
Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19
European Journal of Clinical Pharmacology 77(9) (2021)
Nils von Hentig
Natural Products as Anti-COVID-19 Agents: An In Silico Study
Coronaviruses 2(5) (2020)
Chandan Kumar Sarkar; Sarmin Jamaddar; Milon Mondal; Abul Bashar Ripon Khalipha; Muhammad Torequl Islam; Mohammad Suleiman Mubarak
FDA recommended potent drugs against COVID-19: Insight through molecular docking
Materials Today Proceedings 45 (2021)
Khushbu Gumber; Pomila
An update on COVID-19 outbreak: The longest pandemic
Biological Sciences 02(01) (2022)
Seema Mahor; Hina Chadha; Sarita Prajapati; Sudhanshu K. Mishra; Smriti Ojha
Drug Safety Issues in Therapy COVID-19
The Russian Archives of Internal Medicine 10(3) (2020)
D. G. Levitova; Svetlana Alexandrovna Gracheva; A. S. Samoylov; Ur.D. Udalov; Evgeniy A. Praskurnichiy; Oleg V. Parinov
A Recent Update on Therapeutics to Treat Emerging n-COVID 19: A Review
Coronaviruses 2(7) (2020)
Sumel Ashique; Navjot Kaur Sandhu; Sk. Niyamul Haque; Kartick Koley
Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19
Mini-Reviews in Medicinal Chemistry 21(8) (2020)
Ekta Shirbhate; Preeti Patel; Vijay K. Patel; Ravichandran Veerasamy; Prabodh Chander Sharma; Barij Nayan Sinha; Harish Rajak
Remdesivir e lopinavir/ritonavir frente ao novo coronavírus: breve revisão
VITTALLE - Revista de Ciências da Saúde 32(1) (2020)
Lara Beatriz Ferreira; Daniela Fernandes Ramos
Covid-19 in Children: A Review of Manifestations and Treatment Options
The Anatolian Journal of Family Medicine (2020)
Olayinka Rasheed Ibrahim
Potential Dancer Resistance to Covid-19 Exposure
Proceedings of the International Seminar of Science and Applied Technology (ISSAT 2020) (2020)
Nurida Finahari; Gatut Rubiono
Finding a prospective dual-target drug for the treatment of coronavirus disease by theoretical study
Journal of Biomolecular Structure and Dynamics 40(23) (2021)
Karim Mahnam; Zahra Ghobadi
Potential antiviral therapies for coronavirus disease 2019 (COVID-19)
Elsevier eBooks (2022)
Jasdeep Singh; Divya Singhal
An Overview of COVID-19: Focus on Pharmacological Aspect
SBV Journal of Basic Clinical and Applied Health Science 3(2) (2020)
Nandhini Saravanabavan; Padmavathi Shanmuganathan; Manimekalai Kumarappan; Kartik Janardan Salwe; Barathane Datchanamurthy; J. Johan Pandian; R. Sudar Codi; Vimala Ananthy; Kamalasundar Thanuskodi; Uma Narayanamurthy
Control and therapeutics for covid-19
Indian Journal of Health Sciences and Care 7(2) (2020)
Shweta Sharma; Angelika Batta; Vinod Kapoor; Kapil Hazarika
Available Antiretrovirals in the Treatment and Pre-Exposure Prophylaxis of SARS-CoV-2: Quo Vadis?
Intervirology 64(1) (2020)
Miguel Alpalhão; Paulo Filipe
COVID-19: CURRENT PHARMACOLOGICAL THERAPEUTIC APPROACHES
Universal Journal of Pharmaceutical Research (2021)
Mai El-Sayed Ghoneim; Asmaa A. Khalifa; Bassma M. Ali
COVID-19 pandemic: The deadly respiratory disease of 21st century
Current Research in Pharmaceutical Sciences 11(1) (2021)
Shweta Jain; Pankaj Kumar Jain; Ramakant Yadav; Surendra Jain; Ankur Vaidya
A review on corona virus pandemic: Update on epidemiology, diagnosis, and treatment
Pure and Applied Biology 11(1) (2021)
Mishal Rani
POTENTIAL OF CURATELLA AMARICANA L. AGAINST SARS-COV2: BIOAVAILABILITY, MOLECULAR SIMILARITY AND MOLECULAR DOCKING BETWEEN SECONDARY METABOLITES AND PROTEASE TYPE 3-CHYMOTRYPSIN (3CLPRO)
Journal of the Chilean Chemical Society 66(3) (2021)
Emildo Marcano; Ysbelia Sánchez
Computational Approaches for Lead Discovery against SARS-CoV-2 3C-Like Protease: Virtual Screening and Molecular Dynamics Studies
Journal of Medicine and Health Studies (2023)
Mohammad Kalim Ahmad Khan; Feras Almarshad
Probable selective compounds for inhibition of SARS-CoV-2 infection: A review
The Thai Journal of Pharmaceutical Sciences 45(5) (2021)
Nagaraju Rajendraprasad
Investigating the mechanisms of ethanol-induced disruption of COVID-19 lipid bilayers through molecular dynamics simulations
Journal of Molecular Modeling 31(4) (2025)
Azadeh Kordzadeh; Ahmad Ramazani S. A.
Lipophilic Efficiency as an Important Metric in the Design of SARS coronavirus 3C-like proteinase (3CL-pro) Inhibitors: Guidepost towards Lead Selection and Optimization in the Treatment of COVID-19
ASRIC Journal on Health Sciences 1(1) (2021)
George Oche Ambrose; Joseph Igbo Enya; Tamonokorite AbelJack-Soala; Bukola Temitope Fabunmi; Ajayi Kolawole Temidayo; Bankole Olukayode Olusola